Volume | 85,619 |
|
|||||
News | - | ||||||
Day High | 4.00 | Low High |
|||||
Day Low | 3.80 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Akoya BioSciences Inc | AKYA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
3.88 | 3.80 | 4.00 | 3.81 | 3.90 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,151 | 85,619 | $ 3.88 | $ 332,411 | - | 3.04 - 8.80 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:00 | formt | 521 | $ 3.81 | USD |
Akoya BioSciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
188.7M | 49.14M | - | 96.63M | -63.32M | -1.29 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Akoya BioSciences News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AKYA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.95 | 4.11 | 3.77 | 3.89 | 192,209 | -0.14 | -3.54% |
1 Month | 4.91 | 4.99 | 3.77 | 4.21 | 154,560 | -1.10 | -22.40% |
3 Months | 5.07 | 6.31 | 3.77 | 5.05 | 185,662 | -1.26 | -24.85% |
6 Months | 3.65 | 6.31 | 3.04 | 4.82 | 175,099 | 0.16 | 4.38% |
1 Year | 7.30 | 8.80 | 3.04 | 5.40 | 189,609 | -3.49 | -47.81% |
3 Years | 23.08 | 23.4426 | 3.04 | 10.08 | 148,943 | -19.27 | -83.49% |
5 Years | 26.00 | 28.94 | 3.04 | 10.39 | 151,172 | -22.19 | -85.35% |
Akoya BioSciences Description
Akoya Biosciences Inc is an innovative life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. |